TACR1 and pachyonychia congenita: To date, more than 300 non-peptide NK-1 receptor antagonists have been reported and the question therefore arises as to which is the best non-peptide NK-1 receptor antagonist for use in the prevention/treatment of chronic pancreatitis and PC.